SCHEMBL30295359

SCHEMBL30295359

CC(C)[Si]1(C(C)C)OC[C@H]2O[C@@H](n3ccc4ccccc43)[C@H](OC(=O)c3ccccc3NC(=O)OC(C)(C)C)[C@@H](OP(=O)(OCc3ccccc3)OCc3ccccc3)[C@@H]2O[Si](C(C)C)(C(C)C)O1

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ CTSS P25774 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25101187 0.87 RXFP1 (0.31) —
SCHEMBL30295285 0.87 RXFP1 (0.31) —
SCHEMBL30295223 0.87 — —
SCHEMBL30295374 0.84 — —
SCHEMBL31108454 0.84 — —
SCHEMBL31082815 0.81 P2RY2 (0.39) —
SCHEMBL30295220 0.81 P2RY2 (0.39) —
SCHEMBL25101152 0.73 HTR3E (0.32) —
SCHEMBL30295273 0.73 HTR3E (0.32) —
SCHEMBL31083170 0.70 RXFP1 (0.34) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4392037-A1 THERAPEUTIC COMPOSITIONS AND RELATED METHODS Boyce Thompson Institute for Plant Research Inc. (US) 2024-07-03 — — EP disclosed
WO-2023028350-A1 THERAPEUTIC COMPOSITIONS AND RELATED METHODS BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. (US) 2023-03-02 — — WO disclosed
Send feedback